ECELLFrance - Crunchbase Company Profile & Funding

Overview

ECELLFrance

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About ECELLFrance

CB Rank

2581682

ECELLFrance is a research infrastructure for regenerative medicine and mesenchymal cellular therapy.

Founded

obfuscation

Private

Montpellier, Languedoc-Roussillon, France

1-10

www.ecellfrance.com

Biotechnology

Government

Health Care

Medical

Details

Legal Name

ECELLFrance

Operating Status

Active

Company Type

For Profit

About the Company

ECELLFrance is a governmental research infrastructure open to external teams, providing services covering the entire cell production and development pipeline from proof of concept to clinical trials. They use adult stem cells mesenchymal from the patient and donor experimental treatment to treat numerous medical conditions.

Phone Number

+33 04 67 33 57 22

Contact Email

contact@ecellfrance.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Mesenchymal Stem Cell (MSC) Production

Production of adult mesenchymal stem cells from bone marrow or adipose tissue for use in cell therapy research and clinical trials.

Advanced Therapy Medicinal Products (ATMP) Production Platforms

Technological platforms for producing cell-based therapies compliant with regulatory standards, supporting non-clinical and phase 1 & 2 clinical trials.